Non-Invasive Measurement of SjvO2 Using Near Infrared Spectroscopy in Critically Ill Patients

NCT04624009 | Completed

• 1 other identifier: SjvO2 vs ScvO2 / HUG-DMA
• Study Type: observational
• Target: 35
• Locations: 1 country
• Sites: 2

Brief Summary

ScvO2 is an important parameter in the management of critically ill patient. The only way to measure it is to have an internal jugular or subclavian central venous catheter. With this trial, the investigators want to show a positive relationship between invasive ScvO2 measurement and noninvasive SjvO2 measurement with VO 100 medical device from Mespere LifeSciences, allowing the use of SjvO2 as a noninvasive surrogate of ScvO2 in critically ill patients.

Conditions

Impaired Oxygen Delivery; Critically Ill Patient

Keywords

Brain oxygen delivery; Jugular Venous Oxygen Saturation; Central Venous Oxygen Saturation; Medical Device Use

Outcome Measures

Primary Outcomes (1)

• Comparison of venous oxygen saturation 1

  Comparison of ScvO2 values from CVC blood sample and SjvO2 values from the VO 100 (% oxygen saturation)

  On admission to the intensive care unit

Secondary Outcomes (2)

• Comparison of venous oxygen saturation 2

  3 days after admission into the intensive care unit

• Comparison of venous oxygen saturation 3

  On admission to internal medicine ward

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

ICU adult patients routinely equipped with a central venous catheter placed in internal jugular or subclavian vein

You may qualify if:

• all ICU adult patients routinely equipped with a central venous catheter placed in internal jugular or subclavian vein allowing ScvO2 measurement from blood sampling.
• The investigators will perform this study only on patients already equipped with an internal jugular CVC. In other words, the placement of the CVC is not conditioned by the study realization.

You may not qualify if:

• patients with CVC placed in another site than internal jugular vein.

Sponsors & Collaborators

• University Hospital, Geneva: lead

Study Sites (2)

University of Geneva

Geneva, 1211, Switzerland

Location

Eduardo Schiffer

Veyrier, 1255, Switzerland

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: August 7, 2020
• First Posted: November 10, 2020
• Study Start: January 1, 2022
• Primary Completion: April 1, 2023
• Study Completion: August 1, 2023
• Last Updated: November 29, 2023

Record last verified: 2022-05

Locations

CH (2)